Cargando…
Astragaloside IV reduces the expression level of P-glycoprotein in multidrug-resistant human hepatic cancer cell lines
Astragaloside is a saponin widely used in traditional Chinese medicine and has been reported to be a potent multidrug resistance (MDR) reversal agent. The present study investigated the role of astragaloside IV (ASIV) in the regulation of P-glycoprotein (P-gp, encoded by the mdr1 gene) and its effec...
Autores principales: | WANG, PEI-PEI, XU, DU-JUAN, HUANG, CAN, WANG, WEI-PING, XU, WEN-KE |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055740/ https://www.ncbi.nlm.nih.gov/pubmed/24676670 http://dx.doi.org/10.3892/mmr.2014.2074 |
Ejemplares similares
-
P-glycoprotein Inhibitor Tariquidar Potentiates Efficacy of Astragaloside IV in Experimental Autoimmune Encephalomyelitis Mice
por: Zhang, Wei, et al.
Publicado: (2019) -
Astragaloside IV Reduces OxLDL-Induced BNP Overexpression by Regulating HDAC
por: Zhang, Wenting, et al.
Publicado: (2021) -
Effects of Astragaloside IV on heart failure in rats
por: Zhao, Zhuanyou, et al.
Publicado: (2009) -
Protective Effect of Astragaloside IV on Hepatic Injury Induced by Iron Overload
por: Xie, Dongyu, et al.
Publicado: (2019) -
Network Pharmacology and Experimental Evidence Identify the Mechanism of Astragaloside IV in Oxaliplatin Neurotoxicity
por: Xu, Jingyu, et al.
Publicado: (2021)